EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A signaling molecule from intratumor bacteria promotes trastuzumab resistance in breast cancer cells

Gege Qin, Xiying Shao, Xiaolong Liu, Jiachao Xu, Xiaojia Wang, Wenxi Wang, Lu Gao, Yuxin Liang, Lina Xie, Dan Su, Hongwei Yang, Wei Zhou und 1 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2421710122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Gege Qin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Nanostructure and Nanotechnology, Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry,…. Hauptthemen laut MEDLINE: Breast Neoplasms, Drug Resistance, Neoplasm, Trastuzumab, Pseudomonas aeruginosa. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Key Scientific Program of China, The National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidence indicates that intratumor bacteria exist as an active and specific tumor component in many tumor types beyond digestive and respiratory tumors. However, the biological impact and responsible molecules of such local bacteria–tumor direct interaction on cancer therapeutic response remain poorly understood. Trastuzumab is among the most commonly used drugs targeting the receptor tyrosine-protein kinase erbB-2 (ErbB2) in breast cancer, but its resistance is inevitable, severely limiting its clinical effectiveness. Here, we demonstrate that the quorum-sensing signaling molecule N-(3-oxo-dodecanoyl) homoserine lactone (3oc), a chemical compound released by Pseudomonas aeruginosa ( P. aeruginosa ), one tumor-resident bacteria with a relative high abundance in breast cancer, promotes breast cancer cell resistance to trastuzumab. Mechanically, 3oc directly leads to spontaneous dimerization of the transforming growth factor β (TGF-β) type II serine/threonine kinase receptor on the cell membrane in a ligand-independent manner. The 3oc-induced TGF-β signaling subsequently triggers ErbB2 phosphorylation and its downstream target activation, overcoming the inhibition effect of trastuzumab on ErbB2. With specific real-time qPCR, fluorescence in situ hybridization imaging, and liquid chromatography ionization tandem mass spectrometry analyses of clinical samples, we confirmed that P. aeruginosa and its signaling molecule 3oc exist in breast cancer tissues and there is a clinical correlation between P. aeruginosa colonization and trastuzumab resistance. This work expands the biological functions of intratumor bacteria in cancer treatment responsiveness and provides a unique perspective for overcoming trastuzumab resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDrug Resistance, NeoplasmTrastuzumabPseudomonas aeruginosaErb-b2 Receptor Tyrosine KinasesSignal TransductionHumansFemaleCell Line, Tumor4-ButyrolactoneQuorum SensingAntineoplastic Agents, ImmunologicalTransforming Growth Factor beta

Stichwörter der Autor:innen

bacterial signalingintratumor bacteriatargeted therapytrastuzumab resistance

Substanzen

TrastuzumabErb-b2 Receptor Tyrosine Kinases4-ButyrolactoneAntineoplastic Agents, ImmunologicalTransforming Growth Factor betaERBB2 protein, human

Autor:innen und Institutionen

  • Key Laboratory of Molecular Nanostructure and Nanotechnology, Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
  • Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310022, Zhejiang, China.
  • Department of Basic Medical Sciences, School of Medicine, Tsinghua-Peking Center for Life Sciences, Institute of Immunology, Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing 1…
  • Department of Breast Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China.

ORCID-Profile: Xiaohong Fang

Förderung

  • The National Key Scientific Program of China
  • The National Natural Science Foundation of China

Zitieren

APA

Qin, G., Shao, X., Liu, X., Xu, J., Wang, X., Wang, W., Gao, L., Liang, Y., Xie, L., Su, D., Yang, H., Zhou, W., & Fang, X. (2025). A signaling molecule from intratumor bacteria promotes trastuzumab resistance in breast cancer cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2421710122

Vancouver

Qin G, Shao X, Liu X, Xu J, Wang X, Wang W, et al. A signaling molecule from intratumor bacteria promotes trastuzumab resistance in breast cancer cells. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2421710122

BibTeX
@article{Qin2025,
  author = {Qin, Gege and Shao, Xiying and Liu, Xiaolong and Xu, Jiachao and Wang, Xiaojia and Wang, Wenxi and Gao, Lu and Liang, Yuxin and Xie, Lina and Su, Dan and Yang, Hongwei and Zhou, Wei and Fang, Xiaohong},
  title = {A signaling molecule from intratumor bacteria promotes trastuzumab resistance in breast cancer cells},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2421710122}
}
Kostenlos starten →